Pages that link to "Q40116858"
Jump to navigation
Jump to search
The following pages link to Adriamycin therapy in American patients with hepatocellular carcinoma (Q40116858):
Displaying 9 items.
- Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma (Q33379651) (← links)
- A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas (Q34611637) (← links)
- Current management of advanced hepatocellular carcinoma (Q37072518) (← links)
- Right trisegmentectomy for hepatic neoplasms (Q37311026) (← links)
- Molecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and future (Q38212573) (← links)
- No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma (Q40691152) (← links)
- Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma (Q70178440) (← links)
- Approaches to a selective chemotherapy of hepatocellular carcinoma (author's transl) (Q72899473) (← links)
- Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma (Q80224586) (← links)